Ignavine: a novel allosteric modulator of the μ opioid receptor-Reference-Cited by-同舟云学术

Ignavine: a novel allosteric modulator of the μ opioid receptor

Published:2016-08-17 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Ohbuchi Katsuya,Miyagi Chika,Suzuki Yasuyuki,Mizuhara Yasuharu,Mizuno Keita,Omiya Yuji,Yamamoto Masahiro,Warabi Eiji,Sudo Yuka,Yokoyama Akinobu,Miyano Kanako,Hirokawa Takatsugu,Uezono Yasuhito

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep31748.pdf

Reference32 articles.

1. Takizawa, Y., Isono, T., Suzuki, Y., Hayakawa, Y. & Oyama, T. [Analgesic effects of Tsumura-shuuji-bushi-matsu and mesaconitine]. Nihon Yakurigaku Zasshi. 100, 307–316 (1992).

2. Xu, H. et al. Pain-relieving effects of processed Aconiti tuber in CCI-neuropathic rats. J. Ethnopharmacol. 103, 392–397 (2006).

3. Isono, T. et al. The analgesic mechanism of processed Aconiti tuber: the involvement of descending inhibitory system. Am. J. Chin. Med. 22, 83–94 (1994).

4. Shibata, K. et al. The astrocyte-targeted therapy by Bushi for the neuropathic pain in mice. PLoS One 6, e23510 (2011).

5. Mitamura, M., Boussery, K., Horie, S., Murayama, T. & Van de Voorde, J. Vasorelaxing effect of mesaconitine, an alkaloid from Aconitum japonicum, on rat small gastric artery: possible involvement of endothelium-derived hyperpolarizing factor. Jpn. J. Pharmacol. 89, 380–387 (2002).

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach;Medicinal Research Reviews;2024-05-15

2. 2023 Julius Axelrod Symposium: Plant-Derived Molecules Acting on G Protein-Coupled Receptors;Molecular Pharmacology;2024-03-08

3. Novel 1-(1-Arylimiazolin-2-Yl)-3-Arylalkilurea Derivatives with Modulatory Activity on Opioid MOP Receptors;Molecules;2024-01-24

4. IUPHAR review: Recent progress in the development of Mu opioid receptor modulators to treat opioid use disorders;Pharmacological Research;2024-01

5. Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype;ChemMedChem;2022-05-31